Inhibition of Rat Ovarian 3.BETA.-Hydroxysteroid Dehydrogenase (3.BETA.-HSD), 17.ALPHA.-Hydroxylase and 17, 20 Lyase by Progestins and Danazol.

Publisher Website
Google Scholar
Abstract
The site of action of synthetic progestins or danazol in the treatment of endometriosis is considered to be mainly the hypothalamo-pituitary level, but the direct action to the uterine endometrium and the ovary is also suggested. We investigated the effect of these synthetic steroids to rat ovarian steroidogenic enzymes. The effect of norethisterone, levonorgestrel, danazol, gestrinone, desogestrel and 3-keto-desogestrel was studied in vitro. The sources of the enzymes were prepared from ovaries of immature rats treated either with pregnant mare serum gonadotropin (PMS) and human chorionic gonadotropin (hCG) or 3 .beta.-hydroxy steroid dehydrogenase (3 .beta.-HSD), or with PMS for 17.alpha.-hydroxylase and 17,20 lyase. The substrates used were pregnenolone (P5) for 3 .beta.-HSD, progesterone (P4) for 17 .alpha.-hydroxylase and 17 .alpha.-hydroxy-progesterone (17 .alpha.-OH-P4) for 17,20 lyase. The substrates were incubated with the enzyme sources and coenzymes, and the products formed were measured. All the steroids inhibited 3 .beta.-HSD, and the inhibition by gestrinone (Ki = 3.0 .mu.M) and 3-keto-desogestrel (17.5 .mu.M) was particularly marked. Only desogestrel (Ki = 30.3 .mu.M) and danazol (168 .mu.M) inhibited 17 .alpha.-hydroxylase. All the steroids inhibited 17,20 lyase, and the inhibition by desogestrel (KI = 0.70 .mu.M), danazol (0.80 .mu.M), and gestrinine (30 .mu.M) was particularly marked.